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Opening  
 
This is my expert opinion based on experience and research (full CV attached in 
Appendix One) in relation to the questions posed by the Commission and outlined in the 
Summary below. All assertions I make and conclusions that I draw are my opinion. 
 
In brief, I am a professor of genetics and molecular biology primarily employed by the 
University of Canterbury, Christchurch, but I consult with permission under the name 
Gendora, Ltd. (http://gendora.net/). Previously, I was a staff fellow at the National 
Institutes of Health, Institute of Allergy and Infectious Diseases in the USA. My PhD in 
Molecular Biology was conferred by the University of Oregon, Eugene, USA and my 
dual undergraduate degrees in biochemistry and molecular biology by the University of 
Wisconsin, Madison, USA. I represented the University of Canterbury at the Royal 
Commission on Genetic Modification. I served a Parliamentary Select Committee as an 
expert witness on “Corngate”. I am listed as a United Nations Expert in Biosafety, serve 
on the Ad Hoc Technical Experts Group for the Protocol on Biosafety (United Nations), 
and have authored nearly one hundred peer-reviewed or scholarly publications in books 
and journals such as Science, Nature, Nature Biotechnology, Trends in Biotechnology and 
others. I have provided expert advice to agencies of the USA, New Zealand and 
Norwegian Governments. 
 
I have no financial conflicts of interest in this matter. As far as I am aware, I hold no 
investments in Inghams Enterprises or its competitors and I have never received research 
funding from Inghams Enterprises or its competitors. 
 
Summary of opinion  
 
The Commerce Commission requested that I research and report to the Commission on 
whether animals exposed to feed containing genetically modified material (“GM feed”) 
do in fact contain “no GM [genetically modified] ingredients”. The provision of expert 
opinion to the Commission was sought in relation to ‘Inghams Enterprises (NZ) Pty 
Limited chicken product/s as advertised as containing “no added hormones, GM 
[genetically modified] ingredients” and sold in New Zealand. I was to comment on 
(including comment on the likelihood of the event occurring) with regard to GM plants 
used in food or feed: 
 
• could DNA from GM plants be transferred to the animal; 
• could GM plants be incorporated into other products sold as chicken products, 
including breading or stuffing; 
• could proteins from GM plants be transferred to the product or could the GM feed 
alter metabolites in the animal; 
• could the GM feed cause physiological or immunological responses in the 
animal? 
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I was not asked to consider the validity of safety claims made in the name of GM-free or 
GM-containing products, biological significance of any reported effects in animals 
exposed to this material, or to evaluate animal welfare issues. 
 
The issue in essence is herein framed as not whether GM feed makes a chicken a product 
of gene (or more commonly called, modern) biotechnology (i.e., a GM chicken), but 
whether the use of GM feed itself might be a GM ingredient.  
 
There is substantial and credible literature that reports the detection of DNA and protein 
unique to GM plants within animals and animal products. In the absence of competent 
and dedicated testing to the contrary, it is not possible to conclude that animals and 
derived products are free of GM material when they have been exposed to GM plants 
through i) feeding, ii) proximity to other animals on GM feed, or iii) subsequent 
processing. The most consistent finding in the literature is that animals not exposed to 
GM feed were unlikely to be contaminated with GM material. 
 
There is compelling evidence that animals provided with feed containing GM ingredients 
can react in a way that is unique to an exposure to GM plants. This is revealed through 
metabolic, physiological or immunological responses in exposed animals. In the absence 
of appropriate testing, it is not possible to conclude that an effect of growing an animal 
on GM feed will not persist to the final product even in the absence of residue from the 
GM material. 
 
The cumulative strength of the positive detections reviewed below leave me no 
reasonable uncertainty that GM plant material can transfer to animals exposed to GM 
feed in their diets or environment, and that there can be a residual difference in animals 
or animal-products as a result of exposure to GM feed. 
 
Explanation of opinion  
 
Background  
Genetic engineering/modification (GE/GM) is one of a family of techniques that are 
internationally recognised under the heading “modern biotechnologies” and the products 
of these techniques are regulated separately from other biotechnologies for assuring their 
safety to human health and the environment (Biosafety Assessment Tool, 2009, 
Heinemann, 2009). Genetic modification involves removing genetic material (nucleic 
acids such as DNA) from the normal physiological context of a cell or virus and 
introducing it into another organism. The technique can introduce new, or delete existing, 
genetic material. Either outcome creates a genetically modified organism (GMO). A 
GMO is made through the use of genetic material from any source whether or not of the 
same species. Even if DNA were isolated from and then introduced back into one-in-the 
same individual, the organism would become a GMO. 
 
Most, perhaps all, commercial GM plants available now for use in making animal feed 
are created by the insertion of DNA. Most of these plants are designed to produce one or 
more proteins according to the code of the inserted DNA, and that then impart an 
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agronomic trait such as herbicide or pest tolerance (IAASTD, 2009). That DNA and any 
associated gene product in the GM plant can be consumed by and may persist in animals. 
 
Animals exposed to GM plants through inhalation or feed may react to their unique 
composition. This reaction may be seen as changes in physiology, metabolites or an 
immune response. 
 
In considering the statement “no GM ingredients”, I was to comment on (including 
comment on the likelihood of the event occurring) with regard to GM plants used in food 
or feed: 
 
• could DNA from GM plants be transferred to the animal; 
• could GM plants be incorporated into other products sold as chicken products, 
including breading or stuffing; 
• could proteins from GM plants be transferred to the product or could the GM feed 
alter metabolites in the animal; 
• could the GM feed cause physiological or immunological responses in the 
animal? 
 
To advertise that something has no GM ingredients is to make a claim that is understood 
in some way by consumers. There is at least evidence from overseas that such labels 
appeal to some consumers. A survey conducted in the USA found that nearly a third of 
respondents to the question “would you be ‘willing to consume meat products from cows 
or chickens fed on GM corn or soybeans?’” responded in the negative (Onyango et al., 
2004). A second USA-based survey found that a large majority of Americans wanted 
chickens fed GM plants to be labelled as such, a simple majority associated some health 
risk with chickens raised on GM feed (Bernard et al., 2005). 
 
European Union regulations presumably also preserve the consumer’s choice to avoid 
GM ingredients when the GMO may be present (above a threshold limit) and in addition 
to the animal that may have eaten it (p. 4 Asensio et al., 2008): 
 
Additionally, according to Regulation (EC) 1830/2003 of the European Parliament and 
of the Council, traceability requirements for food and feed produced from genetically 
modified organisms (GMOs) should be established to facilitate accurate labeling of 
such products, in accordance with the requirements of Regulation (EC) 1829/2003 on 
genetically modified food and feed. Therefore, foods and food ingredients that are to be 
delivered to the final consumer in which either protein or DNA resulting from genetic 
modification is present, are subjected to additional specific labeling requirements. 
 
However, the EU does not require labelling simply because GM feed was used (Kain, 
2007, Novoselova et al., 2007). 
 
Retailers are linking the use of GM feed with the GM status of their animal products (EU 
Commission). For the United Kingdom and Ireland: 
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“All of Marks & Spencer's fresh meat and poultry, salmon, shell eggs and fresh milk 
comes from animals fed on a non-GM diet. The Kepak Group, which controls 60% of 
Irish beef exports, requires some farmers who produce meat for its flagship KK Club 
brand to exclude the use of GM animal feed.  
“All Kepak's chicken meat comes from birds reared on a vegetarian, non-GMO diet. 
The Silver Pail Dairy in Co Cork has signed multi-million euro foreign direct 
investment deals with Baskin Robbins (the world's largest ice-cream retailer) and with 
Ben & Gerry's, to produce GM-free ice cream (made from milk from cows fed a 
certified non-GMO diet) for the European market. 
“Tesco, Sainsburys, M&S and Budgen Stores all have quality labels for meat and dairy 
produce from livestock fed on certified GM-free animal feed. All of Marks & Spencer's 
fresh meat and poultry, salmon, shell eggs and fresh milk comes from animals fed on 
non-GM diet. Moreover, standard poultry sold in most UK supermarkets now carries a 
label certifying GM-free feed” (GMO Free Regions). 
 
Similar practices are reported for Italy, France and Switzerland. TraceConsultTM, which 
describes itself as a consultancy, reported on 20 July 2009 that the Swedish Dairy 
Association “were suddenly unable to continue their claim of supplying GMO-free milk” 
due to inadvertent distribution of GM feed to member farmers (TraceConsult). According 
to a translation of the Swedish agricultural business newspaper ATL, the Swedish milk 
giant “Arla was informed [of the feed mix-up] earlier in the week. The company has 
promised consumers that their milk is GM-free in every step. ‘Now we cannot keep that 
promise, which is a concern’” (TraceConsult). 
 
Consumers may have different and complex reasons for wishing to avoid GM ingredients 
(Frewer, 2003, Novoselova et al., 2007). As the UK Food Standards Agency says: “some 
people will want to choose not to buy or eat genetically modified (GM) foods, however 
carefully they have been assessed for safety” (UK FSA). It is not within the brief of this 
report to list or evaluate what those reasons may be. However, I also do not assume that 
all consumers of this type wish to avoid GM ingredients solely because they are reacting 
to the DNA that may have been used to produce GM plants, or the unique protein(s) that 
those plants make. There are other associated social issues, agricultural technologies and 
processes that are inseparable from the use of GM plants. For example, most GM 
soybeans are modified to be tolerant of a commercial herbicide which, because of the 
modification, may be applied directly to the GM soybeans, more frequently or at higher 
doses than it could be on conventional soybeans. A consumer may be wishing to avoid 
any food chain effect of the herbicide. The market-dominating herbicides and their 
corresponding tolerant GM maize, cotton, oilseed rape, and soybean varieties are owned 
by large multinational corporations. A consumer may wish to avoid contributing to this 
kind of business (Novoselova et al., 2007). 
 
I was not asked to consider the validity of safety claims, e.g., whether eating GM plants 
poses an overall health risk to the animal or transfers a health risk to humans through the 
animal. Likewise, whether significant differences between animals fed GM-derived 
substances were of ‘biological significance’, or within the range of physiological 
diversity seen in those species, was not considered. 
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Much research in this field is meant to contribute to the formation of a judgment about 
the overall similarity between GM and conventional organisms, or to detect an adverse 
effect of genetic engineering or from consuming a GMO. Papers that may report 
significant differences may not herald these facts in the abstract, summary or conclusion, 
because the presence of significant differences was not the focus of the research exercise. 
The focus of many of these papers is on endpoints not pertinent to the matter at hand. 
Conclusions of overall nutritional equivalence or efficacy, animal performance and health 
do not establish or disprove the possibility that animals provided with GM feed, or in the 
proximity of other animals provided this feed, are changed in a measurable way. My 
purpose was to consider whether there was evidence that animals eating GM plants could 
be demonstrated to be different from those that have not, in the ways outlined below, 
regardless of whether any individual difference would be sufficient to cause the authors 
of the research to be concerned about overall adverse effects or performance. 
 
Does the current evidence support the contention that a consumer would be, with a high 
likelihood, able to avoid ingestion of DNA, protein or other substances that might be 
unique to a GM plant or its method of cultivation and processing, or able to avoid animal 
physiological or immunological responses to substances unique to GM plants, through 
consumption of animals raised on GM feed (Figure 1)? The answer is no. 
 
Figure 1. Pathways of exposure to GM plant material. 
 
The research is clear on the following. If a consumer were avoiding the ingestion of DNA 
unique to a GM plant by avoiding animals fed GM plants, then this consumer would have 
a high likelihood of success purchasing meat products from animals raised on GM-free 
feed. For products that are breaded or stuffed, that consumer could probably avoid 
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exposure to the DNA unique to a GM plant if the ingredients in the breading and stuffing 
were certified organic or GM-free. If a consumer were avoiding the ingestion of proteins 
or metabolites unique to GM plants, then this consumer would have a high likelihood of 
success purchasing meat products from animals raised on GM-free feed. If a consumer 
were avoiding the ingestion of metabolites or proteins in animals that were only present, 
or present at different concentrations, when the animal was fed a GM plant, then this 
consumer would have a high likelihood of success purchasing meat products from 
animals raised on GM-free feed.  
 
A priori  
Commerce Commission investigators provided me with copies of Inghams’ 
advertisements. Claims in these advertisements and others I sourced independently are 
represented by the following selected quotes:  
 
“Ingham is committed to sourcing non-GM ingredients for its poultry feeds and uses its 
best endeavours to source non-GM ingredients. Because these ingredients must meet 
specific quality standards and be available in quantities that are economically 
sustainable, Ingham chickens may sometimes consume poultry feed which could 
contain GM ingredients. This does not however compromise the absolute GM-free 
status of Ingham chicken products. 
 
“Research confirms that animals that consume feed with a component of GM are no 
different compared to animals that have been fed a low GM or GM free diet. 
 
“Inghams meets or exceeds all regulatory guidelines, script of practice and standards in 
New Zealand and Australia…As is the case with all Inghams products, our chickens 
contain no GM content and are not genetically modified.”  
And 
“The use of GM Soya in feed does not compromise the absolute GM-free status of the 
poultry products the company produces. Animals that eat feed with a component of 
GM Soya are no different to other animals that may have been fed a low GM or GM-
free diet. This position is verified by numerous feeding studies:  
 
(i) ‘NZ Royal Commission Report & Recommendations (2001)’ 
(ii) ‘Federation of Animal Science Societies (2000) FASS Facts, On Biotech Crops - 
Impact on Meat, Milk and Eggs. Savoy IL’ 
(iii) ‘The Royal Society (2002) Genetically modified plants for food use and human 
health - an update. Policy document 4/02 (February)’” 
(http://www.inghams.co.nz/consumernz/aboutus.aspx?docId=285). 
 
Of the documents that Inghams uses as references for its position, all are at least seven 
years old, which is remarkably old in such an active area of science and intense public 
interest. Importantly, one of the three references used, The UK Royal Society’s 2002 
Update, does not address the issue of what constitutes “GM free”. It mentions a few older 
animal studies looking for detection of DNA in animals fed GM feed, and concludes that 
“DNA present in food can find its way into mammalian cells at some low frequency” (p. 
9). The document called FASS Facts which I sourced from the internet is not a scholarly 
publication with references, but appears to be a brochure. I reproduce this document in 
Appendix Two. The NZ Royal Commission reported in Chapter 8 (paragraphs 121-126) 
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that they had heard from a variety of sources, including the predecessor of Food 
Standards Australia New Zealand and a submitter from Iowa State University that there 
were as of 2000-1 no detectable human health issues proven to be related to the use of 
GM plants as animal feed, and that under present labelling laws animals that consumed 
GM plants were not considered “genetically modified”. While the Royal Commission 
deliberated on the evidence of safety to humans, I could find no deliberation on the 
specific issue of whether chickens or other food animals fed GM plants would constitute 
the use of GM ingredients. Their concluding paragraph on this issue was: 
 
“Products from animals or birds fed on genetically modified pasture or stock feed do 
not require assessment under Division 1 of Standard A18 because they are not 
considered to be genetically modified, nor will they require labeling under the labelling 
provisions to be implemented later this year. It is important that consumers are able to 
choose to avoid consuming the products of animals and birds fed on genetically 
modified feed. Where a claim that animals and birds have not been fed genetically 
modified food can be sustained, labelling that identifies the product as being free of 
genetic modification will be appropriate. We discuss genetic modification-free 
labelling later in this chapter. Without such a label, consumers must assume that a 
genetically modified food may have been used” (paragraph 126, emphasis added). 
 
The above and the Royal Commission’s recommendation 8.2: 
 
“that Government facilitate the development of a voluntary label indicating a food has 
not been genetically modified, contains no genetically modified ingredients and has not 
been manufactured using a process involving genetic modifification [sic]” 
 
in my opinion indicate that the Royal Commission saw that it was important to clearly 
differentiate between that which was GM or raised on GM feed, from those things that 
were not GM or exposed to GM feed. 
 
In sum, the references that Inghams Enterprises uses to support its claims are both out of 
date and of questionable support for its policy position. 
 
Is there evidence of DNA unique to GM plants in animals given GM feed?  
 
Yes, albeit that DNA is inconsistently detected. Inconsistent detection is not unusual. 
Especially when the proportion of input material containing the DNA can vary from time 
to time or between consignments, it would be expected that target DNA sequences in the 
food chain may fall below limits of detection of present methodologies (Heinemann et 
al., 2004). Inconsistency in detection is not evidence against the possibility that this 
material can be found in animals, only that the absolute amounts in animals varies above 
and below the detection limit (Alexander et al., 2007, Einspanier et al., 2004, Mazza et 
al., 2005). 
 
There are convincing demonstrations that within animals fed commercial GM plants 
there can be DNA unique to those plants. Here I summarise examples of positive 
detections. This is not a comprehensive survey of the literature and not balanced for 
reports of no detection. For that, see Alexander et al. (2007). The focus here is on positive 
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detections because the purpose of this report is to establish if the science indicates that 
the DNA of GM plants can be in animal products. 
 
Pigs 
Pigs were fed on controlled diets with some groups receiving 60% GM and some 
conventional maize (Chowdhury et al., 2003). DNA unique to the transgene used in GM 
maize event Bt11 was detected in pig stomachs, small intestine (duodenal, ileum), rectal 
and cecal contents but not in peripheral blood. Others have reported detection of DNA 
unique to GM plants in the blood of pigs fed GM- but not conventional-maize (Mazza et 
al., 2005). The first set of authors concluded that “maize DNA and GM DNA were 
considered not totally degraded but rather present in a form detectable by PCR in the 
gastrointestinal tract” (p. 2549 Chowdhury et al., 2003). PCR is a reaction that is used to 
amplify DNA, to increase the ability to detect it. 
 
Cows 
On an estimated consumption of 24kg of dry matter per day, a dairy cow can conceivable 
consume 54 μg/day of DNA unique to a GM plant (Agodi et al., 2006) and 7.4 mg of 
protein unique to a GM maize plant such as MON810 (Alexander et al., 2007). Neither 
proteins nor DNA sequences uniquely from GM plants have been detected by some 
researchers in the milk of cows fed for short times on GM plants (Guertler et al., 2009, 
Phipps et al., 2002, Phipps et al., 2003). However, in a survey of milk products sold in 
stores in Italy, researchers found evidence of target DNA unique to GM plants in 38% of 
samples, including those labelled “organic” (Agodi et al., 2006). This indicates that 
longer term animal feeding studies may be necessary in testing done with animals. 
Another possible explanation for the Agodi et al. (2006) results is bacterial contamination 
after milking, or contamination of the milk with feed dust after it leaves the animal. 
While the DNA found in commercial milk products may or may not be the full length of 
DNA fragments unique to the GM plant, their presence in commercial milk suggests that 
GM ingredients could persist in animals and cross tissue boundaries or enter the food 
chain in a form that the consumer could directly experience. 
 
Fish 
GM plant-specific target DNA was detected in the gastrointestinal (GI) tract of rainbow 
trout fed on a defatted GM soybean variety. The target DNA was detected for up to three 
days post transfer to a non-GM diet (Chainark et al., 2008). This DNA was subsequently 
detected in leukocytes, head kidney and muscle. The target DNA was confirmed to be 
identical to the DNA in the GM soybeans. 
 
Using Atlantic salmon force fed with purified (naked) DNA added exogenously to food, 
Nielsen et al. (2005) showed that dietary DNA could transfer to organs. DNA was 
detected in all three parts of the intestinal contents, blood, kidney and liver (Nielsen et al., 
2005). In later studies, the DNA detected in the mid-intestine was shown to be 
intracellular. “The present findings demonstrate that Atlantic salmon intestinal cells are 
capable of taking up foreign DNA, both dietary and naked” (p. 541 Sanden et al., 2007). 
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Chickens 
Using quantitative PCR the fate of DNA unique to the GM corn Bt176 was followed in 
broilers. This study found that the DNA was not completely digested and could be 
detected for various lengths of time post-consumption in the crop, proventriculus, 
gizzard, small intestine (duodenum, jejnum, ileum) and finally the caeca and rectum 
(Tony et al., 2003). This same group of researchers reported evidence of plant-specific 
DNA in the blood, pectoral and thigh muscles, liver, spleen and kidney up to four hours 
after feeding, but did not detect the DNA unique to Bt176. No further detection was 
possible after 24 hours from feeding. This finding establishes that DNA can persist, 
circulate and transfer to deeper tissues although any particular fragment may fall below 
the detection limit. 
 
Researchers have found plant-specific DNA on chicken meat in supermarkets (Klotz et 
al., 2002). While the target was not DNA unique to a GM plant per se, “it can be 
considered that an incomplete degradation of ingested DNA fragments may take place in 
the GI tract of birds, enabling the detection of residual plant gene fragments. Due to a fast 
passage of feed through the GI tract of avians the appearance of DNA fragments might be 
more likely than for mammals” (p. 274 Klotz et al., 2002). DNA unique to a GM plant 
would be as likely to persist in animals fed GM-feed as any plant-specific DNA. These 
researchers could not distinguish between several causes of DNA on the chickens, 
including residual undigested DNA from feed or contamination with feed dust which was 
not removed through the slaughter, preparation and packaging process (Figure 1). They 
confirmed that the DNA was from an external source and not because the chickens were 
genetically modified, because the target DNA was not detected in chicken embryos. For 
the purposes of this report, the cause is irrelevant because whether the GM-specific DNA 
is present as a partial digestion product on the meat or whether the meat is contaminated 
as a result of airborne material from GM-feed, it ultimately is on the chicken because of 
the use of GM feed. 
 
“In summary, all results coincide with former propositions about a possible transfer of 
small DNA fragments from feed into distinct farm animals. First data are now available 
for pigs, and a recent report first observing foreign DNA within various chicken organs 
is supported” (p. 274 Klotz et al., 2002). 
 
“All studies on DNA degradation in the GI tract suggest that foreign DNA ingested by 
animals is not completely degraded in their GI tracts” (p. 380-381 Chainark et al., 
2008). 
 
Rats 
Gnotobiotic (free of intestinal microbial flora) and HFA (rats with a human intestinal 
microbial flora) rats were fed on maize flour. Using a quantitative PCR technique, a 
maize-specific single gene (as a surrogate for a GM-specific gene) was detected in the 
upper GI, from stomach to duodenum, and a gene maintained at multiple copies was 
detected throughout the GI down to the jejunum, ileum, caecum, colon and in the faeces 
(Wilcks et al., 2004). 
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Sheep 
The cry1ab toxin gene unique to GM-maize was detected by PCR of rumen juice up to 5 
hours after feeding. Targeting a smaller fragment to increase the efficiency of PCR 
allowed detection up to 24 hours after feeding (Duggan et al., 2003). No DNA was 
amplified from faeces. 
 
Comment 
A report from the European Food Safety Authority (EFSA) emphasised negative 
detections of DNA (EFSA, 2007). A strength of their consideration on the issue of GM 
feed was to consider the entire supply chain including the effects of ensilaging and 
processing on the stability of DNA and proteins. They draw on a review by Flachowsky 
et al. (2007). That review cites a 2003 abstract published in German describing the effects 
of processing on oilseed rape DNA. This abstract apparently reported a decline in the 
ability to amplify DNA specific to a variety of GM oilseed rape as it was toasted for 
longer times. Nonetheless, plant-specific fragments of DNA of at least 248 nucleotide 
pairs were still detected after three toasting treatments. The most rigorous regime was a 
series of four toasting treatments from which a GM-specific DNA fragment of at least 
194 nucleotide pairs could still be amplified. Similarly, Flachowsky et al. cite a 
description of one of their own studies also published as an abstract in 2004 which 
indicates that mechanical treatments had no effect on the stability of DNA from GM 
maize but ensiling did (reference in Flachowsky et al., 2007). Nevertheless, a DNA 
fragment of at least 194 nucleotide pairs that was diagnostic of the GM plant was still 
amplified from ensiled maize after 200 days.  
 
In one study reviewed here, GM plant-specific DNA could not be detected by PCR in the 
rumen fluid of sheep whereas that DNA could be detected in grain-fed sheep (Duggan et 
al., 2003). It is clearly possible that processing steps may influence the quantity of full 
length DNA sequences and full size proteins available to animals. 
 
For the purposes of this report it is not assumed, however, that the entire DNA sequence 
that was modified using the techniques of modern biotechnology must be recovered to be 
relevant. If the recombinant DNA material in the GM plant were 5000 nucleotide pairs in 
length and an unambiguous identification of it could be made from a partially digested or 
degraded fragment now of a few hundred nucleotide pairs in length, the material is not 
GM-free any more than would be a plant made into a product of modern biotechnology 
by the insertion of DNA that was only a few hundred nucleotide pairs in size. 
 
Flachowsky et al. proclaim in the abstract of their review that: “[t]o date, no fragments of 
recombinant DNA have been found in any organ or tissue sample from animals fed” GM 
plants (p. 3 Flachowsky et al., 2007). This strong statement seems to have heavily 
influenced EFSA, but is perhaps misleading. As EFSA admit, the: “DNA introduced into 
crops through recombinant DNA technology is not different from other sources of DNA 
in the diet” (p. 2 EFSA, 2007) and this kind of DNA has unambiguously been found in 
organs and muscle. The proportion of DNA that is being targeted in studies is tiny 
compared to the total dietary DNA intake by the animal. Based on estimates of dietary 
DNA a cow might consume in a day (on feed with a 60% GM content), this target is only 
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0.000094% (or about one 1 millionth) of dietary DNA spread over the volume of the 
animal (Beever and Phipps, 2001). Thus, any detection of a specific fragment of DNA, 
which is already at small concentrations in the animal, is actually dramatic evidence that 
DNA is not thoroughly degraded or digested. These positive detections serve to assure us 
that DNA survives degradation and digestion because single copy DNA markers can be 
recovered from animals. Despite the strong statement in the abstract, the authors more 
cautiously conclude their review by saying: 
 
“However, in the case that plant DNA-fragments should be absorbed, it might be that 
transgenic DNA-fragments are also absorbed” (p. 27 Flachowsky et al., 2007). 
 
In fact, Flachowsky et al. (their Table 27) cite four studies in which a plant-specific DNA 
marker was found in animal muscle, organs, or tissues out of only seven total studies they 
cite for positive detections of plant-specific DNA in animals. Even in this far from 
exhaustive survey of the literature, more than 50% of the studies indicated that dietary 
DNA can pass beyond the GIT of animals and it is only a matter of chance whether the 
detected DNA is natural to the plant or it is recombinant (a product of modern 
biotechnology). Furthermore, unlike this report their survey of the literature included 
papers published only up to 2005. 
 
In most studies in which animals were fed whole foods derived from a GM and 
conventional plant, control animals and diets were used. In general, no GM-specific DNA 
was detected on animals not fed material derived from GM plants. Unless there was a 
breach in handling of material, there appears to be little or no likelihood that a product 
derived from animals raised on conventional plants will ever have DNA from GM plants. 
Thus, a consumer choosing chicken and chicken products from a supplier that does not 
use GM feed could reasonably expect to avoid exposure to GM plant material. 
 
Is there evidence of DNA unique to GM plants in the stuffing, breading or other 
products sold as chicken products?  
 
It is increasingly difficult to source maize and soya flours that are GM-free. However, 
Inghams Enterprises claims that it tests these ingredients before use. 
 
“Inghams abides by all regulations in Australia and New Zealand, regarding food 
safety, labelling and packaging. It has food safety procedures in place to ensure the 
integrity of all its non-GM ingredients and monitors suppliers to ensure that this high 
level of integrity is maintained” 
(http://www.inghams.co.nz/consumernz/aboutus.aspx?docId=285). 
 
Provided that this is the case, and that suppliers meet their testing obligation, then the 
level of GM in these products should be below the labelling threshold if not GM-free.  
 
11   
Gendora, Ltd.   
Is there evidence of proteins unique to GM plants in animals fed GM plants, or 
metabolic differences in these animals?  
 
Yes, but not in every study. This may be expected because of variations in exposure to 
GM material and accumulations of protein near the limit of detection. 
 
Pigs 
Returning to the study of pigs fed on either a diet of conventional or GM maize, using 
both an enzyme-linked immunosorbent assay (ELISA) and immunochromatography 
researchers found in pigs peptides derived from the protein uniquely produced by the GM 
maize and only in pigs fed this maize (Chowdhury et al., 2003). Fragments of the target 
protein were detected in the stomach, duodenum, ileum, cecum and rectum. The 
concentration of the protein in the rectal contents was only reduced 50% from the 
concentration in the feed. While detected protein fragments were smaller than the target 
protein, these fragments were large enough to retain the epitopes used to identify the 
protein, and were on the order of half the size of the original protein (Chowdhury et al., 
2003). Epitopes are structural features of the protein to which an animal raises protein-
specific antibodies. 
 
Cows 
Studies using cows fed conventional or GM (Bt176) maize reported fragments of the 
protein Cry1Ab, which is unique to the GM maize, in the rumen and intestinal juice and 
the fragments remained detectable even in the faeces, but not in washed intestinal 
epithelia tissue. This finding was based on ELISA which can overestimate the amount of 
full size protein because even fragments large enough to retain a recognition epitope will 
be detected. In a follow-up study using immunoblotting instead of an ELISA, the 
majority and perhaps all of the positive results from ELISA were attributed to partially 
digested but still large (34 of 60 kDa) protein fragments (Lutz et al., 2005). 
 
Fish 
Atlantic salmon fed on (MON810) GM maize-derived fish meal differed significantly in 
several metabolites from control animals fed on the conventional equivalent meal 
(Sagstad et al., 2007). 
 
In another study, Atlantic salmon fed on GM-derived full-fat soybean meal (FFSBM) fish 
food differed significantly in several metabolites from control animals fed on the 
conventional equivalent meal. The GM soybeans were modified to be tolerant of the 
commercial herbicide Roundup and not to alter physiological parameters in animals fed 
the soybeans. Nevertheless, 
 
“[m]uscle protein content increased significantly with increased GM FFSBM in diet. 
Also, there were some small differences in the muscle fatty acid profile between fish 
fed GM compared to fish fed [non-GM] FFSBM. Fatty acid 22:6n-3 and the ratio n-
3/n-6 in muscle increased significantly, and the sum of n-6 fatty acids decreased 
significantly, with increasing GM FFSBM” (p. 563 Sagstad et al., 2008). 
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The authors associated lower levels of plasma glucose and triacyl glycerol (TAG) in fish 
fed on GM with higher levels of ‘anti-nutritional factors’ in GM compared to non-GM 
soybeans (Sagstad et al., 2008). In a subsequent study, which may have used different 
varieties of GM and non-GM soybeans but from this same research group, the plasma 
TAG levels were significantly higher in fish on GM meal (Sissener et al., 2009). While 
the actual differences in TAG levels were not reproducible, it is clear that in each case 
fish on the GM meal had a statistically significant difference in metabolites when 
compared to fish on the non-GM meal. The authors draw a different conclusion, saying 
that “[t]he contradictory nature of our results [in the two studies] suggests that this is not 
a “GM-effect”, but rather related to natural variations in levels of anti-nutritional factors, 
antigens, metabolites or other unknown factors in the plants” such as possible herbicide 
residues (p. 115 Sissener et al., 2009). 
 
Over the course of three publications (Sagstad et al., 2007, Sagstad et al., 2008, Sissener 
et al., 2009), this research group consistently saw significant effects of GM-supplemented 
meal on metabolite levels and physiological parameters. The metabolite and 
physiological changes were not identical in magnitude and direction, but that is not 
necessarily a contradiction to be explained. The biochemical path between exposure and 
biological response has not been identified and thus there is no reason to expect that the 
biological response will always be in the same direction or of the same magnitude, 
especially when these studies used different species (soybean and maize), and potentially 
different varieties1, of GM plants. 
 
Interestingly, these three studies were based on material supplied by the Monsanto 
Company, which makes the GM plants used in these experiments. While most other 
research studies reviewed tested their control diets for contamination by GM plants, there 
is no mention of independent testing by this research group. It is possible that the results 
are tainted by contamination, since in other studies where materials are directly sourced 
from Monsanto the control diets were contaminated with GM material (for example, see 
Scheideler et al., 2008, Taylor et al., 2003). Contamination of the control diet would most 
likely cause an underestimation of the number and magnitude of significant differences 
between diets. 
 
Regardless of whether the consistent observation of differences in nutritionally matched 
meals is due to changes in the plant’s DNA or associated agronomic or processing 
technologies may not matter to the consumer who may wish to avoid any effects 
associated with the use of GM plants as animal feed. 
 
Chickens 
A 2002 study funded by the Agriculture Livestock Industry Corporation found no 
evidence that the protein unique to the GM maize variety called Starlink could be 
detected in broiler chicks’ blood, liver or muscles (Yonemochi et al., 2002). Again, 
inconsistencies in detections are not unexpected and the inconsistency of detection does 
                                                 
1 In Sagstad et al. (2008) the variety of soybean is not reported. In Sissener et al. (2009) the variety of GM 
soybean is reported as event GTS 40-3-2. 
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not reduce the certainty that such products are found in animals, only that the absolute 
amount of the substance varies for complex reasons. 
 
A study conducted by the Monsanto Company found that their test strips for the GM 
plant-specific protein Cry3Bb1 (MON863) reacted to eggs from test chickens fed both 
GM-derived feed and conventional feed, as well as eggs purchased from a local store 
(Scheideler et al., 2008). Monsanto researchers interpreted this result as indicating that 
the test strip was triggered non-specifically by some other substance in eggs. There is 
another possibility. The same researchers admitted that the conventional feed used in the 
study was contaminated with GM maize producing the unique target protein Cry3Bb1 
and two of these hens also produced Cry3Bb1 positive faeces (Scheideler et al., 2008). 
Since GM maize is so common in the USA feed supply, the supermarket eggs could also 
have been derived from chickens fed GM maize. Thus, the ability of proteins unique to 
GM feed to pass into eggs is not disproved by this study. 
 
Chickens fed the GM diet had detectable fragments of the Cry3Bb1 protein in their 
faeces, large intestines, cecums, small intestines and crops (Scheideler et al., 2008). 
Based on their quantifications, Monsanto estimated that 98-99% of the dietary Cry3Bb1 
was digested. However, this is not to completion but to the relatively large fragments of 
proteins that are still detected by antibody or polyclonal serum binding. 
 
Comment 
Importantly, in the studies mentioned above, control animals and diets were used. These 
control animals were fed non-GM equivalent material (for an exception, see the flawed 
study by Scheideler et al., 2008). In general, no GM-specific DNA or protein was 
detected from animals not fed material derived from GM plants. 
 
Is there evidence of physiological or immunological responses specific to GM plants 
in the animal?  
 
Most evidence of physiological or immunological response comes from oral ingestion. 
However, animals often breathe in feed dust which can expose the lungs to proteins 
unique to the GM plant. Both exposure routes were considered. 
 
Fish 
Atlantic salmon fed on (MON810) GM maize-derived fish meal differed significantly in 
the activity of catalase (CAT) and Cu/Zn-superoxide dismutase (SOD) enzymes extracted 
from livers as compared to fish fed conventional maize meals. CAT and SOD are part of 
a biochemical pathway that reduces free radicals in cells by converting superoxide anions 
into hydrogen peroxide and ultimately oxygen and water. There was significantly less 
CAT and more SOD activity as measured by enzyme extracted from the liver. There was 
significantly more SOD activity as measured by enzyme extracted from the distal 
intestine. None of these differences was due to changes in mRNA levels for these 
enzymes and thus was attributed to enzyme function (Sagstad et al., 2007).  
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In addition, fish fed GM maize had a significantly higher proportion of granulocytes and 
a lower proportion of lymphocytes compared to fish on conventional maize diets. 
 
“Differential leucocyte counts showed altered proportions of white blood cell 
populations, suggestive of an immune response taking place in the blood as a response 
to the GM maize in the diet” (p. 210-211 Sagstad et al., 2007). 
 
Rats and mice 
Rats fed GM rice uniquely producing the Cry1Ab protein or PHA-E lectin were 
monitored for allergic responses (Kroghsbo et al., 2008). Some of the most significant 
changes were observed in rats on the GM diet for 90 days, where the PHA-E lectin 
caused a dose-dependent increase in IgA (immunoglobulin A) levels, and the absolute 
and relative weight of mesenteric lymph nodes were increased in these animals 
(references within Kroghsbo et al., 2008). Rats fed GM rice uniquely producing Cry1Ab 
had significantly higher white blood cell counts and male rats had reduced adrenals. 
 
Most striking, this study found an antigen (i.e., Cry1Ab or PHA-E)-specific IgG response 
even in control animals (those not fed the GM rice). 
 
“As the nasal and bronchial mucosal sites are potent sites for induction of an immune 
response, the results may be explained by inhalation of particles from the powder-like 
non-pelleted diet containing PHA-E lectin or [Cry1Ab] toxin, thereby inducing an anti-
PHA-E or anti-[Cry1Ab] response…These results support our assumption that the 
induction of the [Cry1Ab]-specific antibody response in the control groups occurred 
after inhalation” (p. 31 Kroghsbo et al., 2008). 
 
Thus, exposure to GM plant material could cause immunological changes in animals 
even if the material is kept out of their food but is used in animals contained within range 
of the feed dust. 
 
In another study in which rats were fed meal using GM or non-GM soya, there were 
reported differences in plasma amylase levels between the two groups of animals. 
Animals fed the GM soya had a transient depletion in zymogen granules and an increase 
in pancreas acinar cell disorganisation, similar to what is observed in pancreatitis. 
Zymogens are inactive enzymes that are secreted from the pancreas and activated when 
needed. Their transient depletion may indicate that the cells recuperated in time. “The 
results appear to indicate that rats fed on a GM diet had a pancreatic supraphysiological 
stimuli or synergism with cholecystokinin (CCK); although not severe, it was sufficiently 
strong to induce a mild pancreatic injury with an adaptive response” (p. 224 Magaña-
Gómez et al., 2008). 
 
Pancreatic acinar cells were also the focus of studies involving the feeding of a GM soya 
diet to mice, compared to a non-GM control soya diet (Malatesta et al., 2003). The 
soybean component of both diets was 14% and the mice presumably began this diet at 
weaning and were sacrificed for analysis at 1, 2, 5 or 8 months of age. Their pregnant 
mothers were also fed the same diet before they were born. In this study, more fibrillar 
centres (FCs) were observed in GM fed mice, and they were on average much smaller in 
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GM fed mice compared to those observed in mice on the control diet. FCs are found in 
the primary nuclear organelle called the nucleolus, the site of ribosome biogenesis 
(Raska, 2003). The authors interpreted this as indications that in GM soya fed mice, 
nucleolar activity is depressed and there could be more general effects on RNA 
processing, ultimately affecting the production of some enzymes in animals on GM feed. 
 
Hepatocytes from the liver of mice were examined after they were maintained on a 14% 
GM or conventional soya diet (Malatesta et al., 2002). 
 
“Hepatocytes are involved in numerous metabolic pathways: they metabolise and 
transform most of the products of digestion, degrade and detoxify substances and 
excrete them in the bile, synthesise many protein components of blood plasma and are 
able to store glycogen and to release glucose, thus playing a primary role in the 
maintenance of carbohydrate homeostasis” (p. 179 Malatesta et al., 2002). 
 
Their mothers had been introduced to the same diet (either GM or conventional) during 
pregnancy. The younger mice began the diet after weaning and were sacrificed for 
analysis at 1, 2, 5 or 8 months old. While gross features of the mice and liver were the 
same between the groups, there were noticeable differences at the sub-cellular level. For 
example, hepatocyte nuclei in GM-fed animals had irregular shapes compared to mice on 
GM for less than one month and the control group throughout the study. The nucleoli of 
GM fed mice were also irregular and less compact, which the authors associated with a 
higher metabolic rate (Malatesta et al., 2002). As above, differences in FCs were 
observed. “[I]n our animals the modifications of FC size...are related to food only” (p. 
178 Malatesta et al., 2002). 
 
In an innovative follow-up study, the mice raised from weaning to three months old on 
the GM diet were given conventional soya in their food and vice versa for the 
conventional control group for one additional month (Malatesta et al., 2005). Mice that 
swapped a conventional for a GM soya diet had more FCs with an associated increase in 
the dense fibrillar component, whereas the other group had more compact nucleoli and 
fewer FCs with a pronounced granular component. The diet swapping experiment caused 
the differences between the mice to reduce, indicating that the some or all effects of GM 
feed may be reversible, and that the GM feed is able to induce rapid changes even in 
adults (Malatesta et al., 2005). 
 
Male mice born of mothers fed either a 14% GM soya or conventional soya diet, and then 
maintained on the parental diet following weaning until 2, 5 or 8 months old had 
observable differences in Sertoli cells of the seminiferous tubule, spermatogonia and 
spermatocytes (Vecchio et al., 2004). Sertoli cells had enlarged vesicles of the smooth 
endoplasmic reticulum (SER) in GM-fed mice. There was a transient (between 2 and 8 
months) increase in the size of nucleoli in GM-fed mice. Perichromatin granules were 
increased, and the number of nuclear pores decreased, in both Sertoli cells and 
spermatocytes of mice on a GM diet (Vecchio et al., 2004). The authors associated these 
changes with a transient decrease in transcriptional activity in these cells. Transcription is 
the central biochemical pathway by which RNA is made. RNA is a key co-factor in 
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protein synthesis and is a catalytic component of ribosomes. Various RNA molecules 
perform roles in regulating gene expression and RNA-processing reactions. 
 
The physiological effects of GM feed observed in this study reversed by eight months of 
age, except for SER dilation (Vecchio et al., 2004). The authors attributed this effect to 
either persistence of herbicide residues uniquely on herbicide-tolerant GM soybean 
varieties or an unanticipated effect of the genetic engineering itself. 
 
Rats fed on a diet with GM-, expressing a lectin for the purpose of pest tolerance, or 
conventional-potato content had significant histopathological differences. Mucosal 
linings from the stomach were thicker for rats on the GM feed (or on conventional 
supplemented with purified lectin). Crypt lengths of the jejunum were greater in rats on 
GM potato (and not on conventional or conventional supplemented with lectin) diets 
(Ewen and Pusztai, 1999). 
 
A study originally conducted under contract to the Monsanto Company in which rats 
were fed GM maize (MON863) or a control diet of conventional maize was reanalysed 
by independent researchers (Seralini et al., 2007). This reanalysis found evidence for 
multiple GM-feed-specific physiological changes in the liver, kidney, pancreas and bone 
marrow of rats, some of which were sex-specific. Liver alkaline phosphatase and alanine 
or aspartate aminotransferase activities differed by 8-23% in GM and non-GM fed rats. 
 
The Seralini et al. (2007) study was affirmed by an Environmental Science and Research 
(ESR) Ltd. analysis (Gallagher, 2007) and later by a second review of the data again 
published under the same lead author but including the ESR, Ltd. author (Seralini et al., 
2009). 
 
Sheep 
Sheep were fed on hay supplemented with GM (Bt176) or non-GM maize over a three 
year period. Using a staining technique, the researchers found evidence of significantly 
different levels of proliferative activation of ruminal epithelium basal cells in ewes fed 
GM maize (Trabalza-Marinucci et al., 2008). “Moreover, preliminary [electron 
microscopy] analyses of hepatocytes and pancreatic acinar cells revealed smaller, 
irregularly shaped cell nuclei containing increased amounts of heterochromatin and 
perichromatin granules (ribonucleoprotein structural components involved in transport 
and/or storage of already spliced pre-mRNA)” in lambs fed GM maize (p. 186 Trabalza-
Marinucci et al., 2008). 
 
Rabbits 
New Zealand rabbits were fed either a diet supplemented with GM-soya (Roundup Ready 
brand) or conventional soya (Tudisco et al., 2006). How the soya was sourced and 
confirmed (as GM or GE free) was not reported. Animals on the GM soya diet had 
significantly higher levels of lactate dehydrogenase (LDH), alanine aminotransferase 
(ALT) and gamma glutamyltransferase (GGT) in kidneys than animals on a conventional 
soya diet. LDH was also significantly elevated in heart muscle (Tudisco et al., 2006). 
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Summary 
 
Inghams Enterprises (Pty) Ltd. does use GM feed at some frequency or proportion of 
total feed. It writes that this practice is consistent with its claims of using no GM 
ingredients because “[r]esearch confirms that animals that consume feed with a 
component of GM are no different compared to animals that have been fed a low GM or 
GM free diet.” However, whether the animals are the same or different in terms of their 
performance or safety as a result of using a particular ingredient in their preparation is not 
what is at issue. The issue is whether the use of GM feed is introducing an ingredient of 
GM into their product. 
 
The references Inghams Enterprises uses to support its position that chickens exposed to 
GM feed are the same as chickens raised on conventional feed are uniformly very old and 
either do not address this issue or in my view do not explicitly support Inghams’ claim. 
The age and suitability of the reference list used to support its GM policy is not consistent 
with its further claim that: 
 
“Inghams understands that there is considerable community interest in the uses of 
genetic modification and we believe it is important to keep customers informed or our 
policies and relevant facts” 
(http://www.inghams.co.nz/consumernz/aboutus.aspx?docId=285). 
 
Table 1: Animal evidence of significant positive detections. 
Animal 
Parameter detected 
Pig Cow Fish Chickens Rabbits Rats 
and 
mice  
Sheep 
GM DNA        
GM protein        
GM-induced 
metabolites 
       
GM-induced 
physiological changes 
       
GM-induced 
immunological 
responses 
       
 
This report is enriched for positive detections of the parameters I was asked to 
investigate. There is a moderately larger pool of published studies that report no effect of 
GM feed on animals (e.g. Alexander et al., 2007, Flachowsky et al., 2007, Pryme and 
Lembcke, 2003). It should be emphasised, however, that the number of research studies 
that report no detection of physiological, immunological or metabolic effects, or absence 
of DNA or protein, is about the same as the number that report detection (e.g. Table 27 
Flachowsky et al., 2007). In the relatively small literature which measures these 
particular parameters, there is a large proportion that reports significantly different effects 
of GM and conventional feed on animals or the presence in animals of DNA and protein 
unique to GM plants.  
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For the purposes of this report it is not assumed that the DNA sequence that was used to 
modify the GM plant must be identical in size to the DNA subsequently found in animals, 
or that any reduction in size of that DNA or its gene product(s) in the animal will make 
that animal “GM-free”. If the recombinant DNA material in the original GM plant were 
5000 nucleotide pairs in length and an unambiguous identification of it could be made 
from a partially digested or degraded fragment now of a few hundred nucleotide pairs in 
length, the material in which this detection is made is not GM-free any more than would 
be a plant made into a product of modern biotechnology by the insertion of DNA that was 
only a few hundred nucleotide pairs in size.  
 
The majority of papers measuring the effects of GM feed measure endpoints, such as 
animal weight, mortality, performance, egg size and weight and animal rate of growth 
(Flachowsky et al., 2007) that are not relevant for reasons mentioned earlier. 
Furthermore, animals fed conventional or GM feed may achieve the same endpoints and 
still have individual and significant differences between them. In addition, many of these 
studies do not use whole food in their testing, but instead the protein unique to the GM 
plant expressed from a surrogate, usually the bacterium Escherichia coli (Pryme and 
Lembcke, 2003). Tests using surrogate sources of protein may not be appropriate because 
commercial animal feed is supplied as a whole food. 
  
To attempt to argue whether animals exposed to GM plants through feed products are 
different from animals only exposed to conventional feed, using a simple tally of the 
number of researchers who detect or do not detect differences would be a mistake. The 
inconsistency of detection as catalogued in literature reports is an indication that there is 
uncertainty in what parameters to measure, what feeding regimes are most informative 
(Pryme and Lembcke, 2003) and what techniques are best suited. The small number of 
researchers in this field is spread over many different animals, varieties and species of 
GM plants and parameters to measure, and thus differences in practitioners’ technical 
expertise or knowledge of the biology, molecular biology, biochemistry and physiology 
involved will be an important contributor to negative results. 
 
The cumulative strength of the positive detections reviewed above leave me no 
reasonable uncertainty that GM plant material can transfer to animals exposed to GM 
feed in their diets or environment, and that there can be a residual difference in animals 
or animal-products as a result of exposure to GM feed (Table 1). 
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Appendix One: Complete CV  
 
 CURRICULUM VITAE 
 
 JACK A. HEINEMANN 
 
 
 
CURRENT POSITIONS: Professor  
 Adjunct Professor (GENØK – Centre for Biosafety) 
 
ADDRESS: School of Biological Sciences (formerly PAMS) 
 University of Canterbury, Christchurch, New Zealand 
 
EMAIL ADDRESS: jack.heinemann@canterbury.ac.nz 
 
TELEPHONE/FAX: 64 03 364-2926/2500 
 
CITIZENSHIP: U.S.A. and New Zealand 
 
EDUCATION:  
1985-1989 Ph.D. in Biology/Molecular Biology 
 University of Oregon, Eugene, OR, USA 
1980-1985 B.Sc(Honours) in Biochemistry 
 B.Sc(Honours) in Molecular Biology 
 University of Wisconsin, Madison, WI, USA 
 
PROFESSIONAL EXPERIENCE: 
2007-present Professor, School of Biological Sciences, University of 
Canterbury 
2003-2007 Associate Professor 
1994-2002 Senior Lecturer 
 
2001-present Director, Centre for Integrated Research in Biosafety, 
University of Canterbury 
 Adjunct Professor, Norwegian Institute of Gene Ecology 
(GENØK), Tromsø, Norway 
 Member, Biomathematics Research Centre (2001) 
University of Canterbury 
 
1997-2000 Biochemistry Programme Coordinator 
 (managed 5 undergraduate courses, ~ 20 postgraduate (PhD 
and MSc) students and 10 academic and technical staff) 
 
1992-1994 Staff Fellow, National Institutes of Health, NIAID, 
 Laboratory of Microbial Structure and Function 
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1989-1992 Intramural Research Training Award Fellow 
 NIAID, NIH, Laboratory of Microbial Structure and 
Function 
   
1985-1989 Graduate student, University of Oregon, Institute of 
 Molecular Biology 
   
1983-1984 Undergraduate Research Assistant, University of 
 Wisconsin-Madison, Department of Biochemistry 
 
INTERESTS AND EXPERTISE: 
Genetics and molecular biology of prokaryotic and eukaryotic microorganisms; 
horizontal gene transfer, particularly conjugation; effects of stress, particularly 
induced by antibiotics; evolution and biosafety risk assessment; eugenics 
(historical); influence of language on science. 
 
HONORS AND SPECIAL RECOGNITION: 
2009 Chosen by the (United Nations) Convention on Biological 
Diversity Secretariat to serve on the Ad Hoc Technical 
Expert Group (AHTEG) on Risk Assessment and Risk 
Management 
 
2008 Chosen by the (World Bank and UN agencies) IAASTD 
Secretariat as author representative to the 
intergovernmental meeting on the IAASTD Report 
 
2007 Selected by the IAASTD Advisory Bureau to serve as an 
author on the Biotechnology theme of the Synthesis 
Report 
 
2006 Appointed Lead Author in the IAASTD Global 
Assessment Report (nominated by Norway) 
  
2005 UN Roster of Experts (Biosafety Protocol) 
 
 Distinguished Lecture in Microbiology, University of 
Wisconsin-Madison 
 
2004 Speaker in the New Zealand Royal Society’s Science for 
Parliament Series 
 
2002 Recipient, New Zealand Association of Scientists 
Research Medal (The Association’s Research Medal is 
awarded each year to a single scientist aged under 40 for 
outstanding research work, principally undertaken in New 
Zealand during the three preceding years.) 
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2002-2004 Editorial Board of Targets (Elsevier “Trends” series 
journal) 
 
2001 Visiting Professor, Norwegian Institute for Gene Ecology 
and the University of Tromsø (with Prof. T. Traavik), 
Tromsø, Norway 
 
 Visiting Scholar, The Rockefeller University (with Prof. J. 
Lederberg), New York, USA 
 
1999-2004 Editorial Board of Drug Discovery Today 
 
1993 Young Investigator Award from the American Society for 
Microbiology Interscience Conference on Antimicrobial 
Agents and Chemotherapy (ICAAC) [one of four awarded 
in an international competition] 
 
1989-1992 Intramural Research Training Award (National Institutes 
of Health) 
1990-2003 Various recognition: National Business Review Achiever of the Week (14 Feb. 2003); 
featured in Saunders, J. 2003. Multiple Drug Resistant Bacteria. Microbiology Today 
(http://www.socgenmicrobiol.org.uk/pubs/micro_today/book_reviews/MTNOV03/MTN03_24.cfm)
; featured in: Delwiche, C.F. 2000. Griffins and Chimeras: Evolution and Horizontal Gene Transfer. 
BioScience 50, 85-87; featured in: Ankenbauer, R.G. 1997. Reassessing Forty Years of Genetic 
Doctrine: Retrotransfer and Conjugation. Genetics 145, 543-549; keynote addresses, The 
Norwegian Biotechnology Advisory Board Meeting (Oslo, Norway, 1997) and International 
Conference on Gene Transfer Mediated by Bacterial Plasmids (Banff, Alberta, Canada, 1990); 
invited speaker, "Microbial Stress Response" Gordon Conference, 1994. 
1980-1989 Undergraduate and graduate school awards include: 1984, Outstanding Senior (final 
year) Student Award (University of Wisconsin-Madison Alumni Association); 1983, Mary Shine 
Peterson Award (Department of Biochemistry, University of Wisconsin); University of Wisconsin 
Forensics Team Scholarship; 1981, Phi Eta Sigma, the Freshman's Honor Society, MACE, the 
Chancellor's Men's Honor Society; 1986-1986 NIH Molecular Biology Predoctoral Traineeship 
(University of Oregon). 
 
GRANTS:  Total value since 1995 ~NZ $3.1 million 
2009-2013 GE Biosafety Forecast Service (NZ $492,000) 
 
2008 GE Biosafety Forecast Service (NZ $123,000) 
 
2006-07 Constructive Conversations (subcontract FRST) 
(NZ$35,000) 
 
2005-07 GE Biosafety Forecast Service (NZ $767,000) 
 University of Canterbury (NZ $30,000) 
 
 United Nations Food and Agriculture Organisation (FAO) 
report on Gene Flow (NZ $50,000) 
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 Erskine Fund Teaching Fellowship (NZ $20,000) 
 
2004 GE Biosafety Forecast Service (NZ $324,000) 
 
2003 GE Biosafety Forecast Service (NZ $31,000) 
 
2002 FRST: Postdoctoral fellowship (to RJ Weld to work in my 
laboratory for 3 years) 
 
 OECD Fellowship (~NZ $40,000 for RJ Weld to work in 
Norway for 6 months) 
 
 Brian Mason Trust: NZ $15,000 for research on GMOs 
 
2001 Miscellaneous: GENØK (US $10,000); Rockefeller 
University (US $6,000); University of Canterbury (US 
$3,000); US-New Zealand ISAT Bi-lateral Relations 
Grant ($3,200) 
 
2000 Marsden Fund (Associate Investigator) (NZ $447,000) 
 Ministry of Health (NZ $3,000) 
 
1999 Marsden Fund (Primary Investigator) (NZ $528,000) 
 Joint U. Canterbury/Crop & Food Res. (NZ $171,000) 
 Ministry of Health (NZ $8,000)  
 
1995-1998 (1998) Lotteries Health Research Grant (NZ $71,350), University of Canterbury Research Award 
(NZ $45,000); (1997) Christchurch School of Medicine Summer Studentship Award (to sponsor an 
undergraduate researcher), Don Beaven Trust Travelling Fellowship (NZ $3,000), University of Canterbury 
Research Award ($20,000); (1996) Lotteries Science Research Grant (NZ $35,000), (1995) University of 
Canterbury Research Award (NZ $25,000), University of Canterbury Equipment Award (NZ $90,000) 
 
CONSULTATIONS, SYMPOSIA and PROFESSIONAL ACTIVITIES: 
 
Spoken at about 25 international conferences (~80% at invitation), presented 4 
keynote addresses and chaired 6 sessions. Served on the organising 
committees of 5 international meetings. Referee on occasion for Applied and 
Environmental Microbiology, Bioessays, Biology Letters Review, Drug 
Discovery Today, FEMS Microbiology, FEMS Microbiology Ecology, Food 
and Chemical Toxicology, Environmental Biosafety Research, 
Environmental Science and Technology, Journal of Applied Microbiology, 
Journal of Bacteriology, Microbiology, Molecular Biology and Evolution, 
Molecular Ecology, Molecular Microbiology, Nature Biotechnology, Nature 
Genetics, New Zealand Journal of Zoology, Pharmacological Research, 
Plasmid, Science and World Journal of Microbiology and Biotechnology, 
and eight granting agencies (NSF, USA; FRST, Marsden, HRC and Lotteries 
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Grants Board, New Zealand; MacQuarie, Australia; NERC and Wellcome Trust, 
UK, Alzheimer’s Foundation, Danish National Research Foundation, Denmark, 
Slovak Research and Development Agency, Slovak Republic). Chief organiser 
of the 1999 International Osmoregulation Conference, Christchurch, New 
Zealand. Organiser and Instructor of two prominent international courses: 
School of Bioinformatics and Genomics Summer Course in Phylogenomics 
(2003, Sweden) and International Biosafety Course (2003-continuing, Norway). 
 
Since 1989 I have been an invited speaker at over 50 academic, governmental or 
industrial institutions in 10 different countries. Recent/upcoming talks: 
 
 CPIT Institute of Polytechnic, Christchurch 
 Dartmouth University, USA 
 Iberamerican University, Dominican Republic 
 Göteborg University, Sweden 
 University of Wisconsin-Madison, USA 
 
2008 Expert witness to Tasmanian Joint Select Committee on 
Gene Technology in Primary Industries (nominated by 
Hon David Llewellyn, Chair) 
 
 Invited Keynote to Feed the World Conference, London 
 
2006 Invited speaker, International Biosafety Symposium 
Meeting of the Parties (MOP3) of the Cartegena Protocol 
on Biosafety, Curitiba, Brazil 
 
Expert reviewer, Denmark Centre of Excellence 
Programme.  
 
2005 Expert reviewer on New Zealand Environmental Risk 
Management Authority’s policy paper: Horizontal Gene 
Transfer  
Keynote Speaker, UNEP/GEF National Biosafety 
Framework Initiative, Dominican Republic 
 
2004 Invited speaker, International Biosafety Symposium 
Meeting of the Parties (MOP1) of the Cartegena Protocol 
on Biosafety, Kuala Lumpur, Malaysia 
 Invited speaker, School of Bioinformatics and Genomics 
Summer Course in Phylogenomics, Göteborg University, 
Sweden 
 
2004-2005 Executive Committee, United Nations Environment 
Programme and GENØK Biosafety Capacity Building 
Partnership 
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2003 Scientific consultant to the New Zealand Parliamentary 
Local Government and Environment Select Committee on 
“Corngate”. 
 Invited Speaker, American Society for Microbiology 
ICAAC conference. 
 
2002 Speaker: ERMANZ conference on Horizontal Gene 
Transfer 
 Microbial Genetics Conference, Bergen, Norway 
 New Zealand Microbiology Society Meeting 
 
2001 Advisor to New Zealand Minister of Science in the 
 “Horizontal Gene Transfer Round Table Meeting” 
 
2000 Expert panel New Zealand Ministry of Health 
 New Zealand PGSF Biotechnology Tender Panel 
 
 University of Canterbury Representative to the NZ Royal 
Commission on Genetic Engineering 
 
1999 Expert Panel on Antibiotic Residues for the New Zealand 
Ministry of Health 
 
1997 Keynote speaker, The Norwegian Biotechnology 
Advisory Board Meeting, Oslo, Norway 
 
1993 Advisor to the United States Department of Energy, under 
the auspices of the American Academy of Microbiology, 
for genetic modification of bacteria 
 
POSTGRADUATE TEACHING (1995-present) 
 
Experience: Primary supervisor of 13 completed MSc theses, 12 BSc (Hons) 
theses and 7 PhD theses, and associate or co-supervisor for more than 20 BSc 
(Hons), MSc and PhD students since joining the University of Canterbury 
(1994). My research laboratory presently has 2 PhD students and 1 postdoctoral 
scholar. 
 
Achievements: My research students received 5 of the 6 poster awards in the 
1996 Queenstown International Molecular Biology Meeting attended by 
researchers from all over the world and uniformly represented by New Zealand 
and Australian universities. Joanne Kingsbury and Tim Cooper, while PhD 
students in my laboratory, won the first and second prizes, respectively, for best 
research talks at the 1998 national meeting of the Microbiology and Biochemical 
Societies of New Zealand. Tim was a postdoctoral scholar at Michigan State 
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University and is now at Auckland University. Joanne is a postdoctoral scholar 
at Duke University. Tim was subsequently nominated for the American Society 
of Microbiology Sternberg Thesis Award. Gayle Ferguson, another of my PhD 
students, won first prize for her talk at the Microbiology Society national 
meeting in 2001 and was a postdoctoral scholar at Columbia University, New 
York. 
 
EXTERNAL TEACHING ACTIVITIES: 
2009 Faculty and Coordinator for the Gateways Partners 
Symposia Course and Conference on (trans)gene Flow, 
Tromsø, Norway 
 
2005  Faculty and organiser of the Solomon Islands Biosafety 
Course 
 
2003-2005 Faculty and instructor International Biosafety Course 
 
2003-4 Principal Organiser and Instructor (2003), Göteborg 
University’s Bioinformatics summer graduate course, 
Sweden 
 
2000-present PhD examiner: 3 x University of Otago; 1x Massey; 2 x 
Lincoln; 1 x Macquarie University; 1 x Dartmouth 
University 
 MSc. examiner: 1 x Massey University, 3 x Otago 
University; 1 x Macquarie University 
 Assessor (MSc proposals): 3 x Auckland University 
  
Teaching experience during NIH (1990-1994), under- and post-graduate years (1980-
1989): 1990-1994 Supervisor, NIH Summer Student Program, Rocky Mountain 
Laboratories, USA (resulting in a research paper in the journal Genetics by an 
undergraduate student in 1996); 1992-2000, University of Montana USA affiliate 
faculty; Guest lecturer, University of Montana, 1992-1994 "Advanced Topics in 
Microbiology", (course 595) University of Montana, Department of Biology; Teaching 
Assistant for Core Biology Lecture and Laboratory, Department of Biology, University 
of Oregon, Eugene, OR, USA; Presenter, Special Project Course in Bioethics, 
Department of Botany, University of Wisconsin, Madison, WI, USA. 
 
STAFF LEADERSHIP ROLES: 
 
Serving the University of Canterbury on 12 ad hoc committees in addition to 
standing committees (listed below): chair of the College of Science Biosecurity 
Programme Committee (2004); Science Faculty Working Committee evaluating 
proposals for establishing a Department of Biochemistry (1995-6); the AUS 
Workloads Committee (1996); lead workshops at the Canterbury-hosted 
Education Forum (1999); and served on the AAC Subcommittee on Appeals 
Procedures (2000). Since 1995, I have served on 3 and chaired 4 Search 
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Committees (total of 7) for new academics. Participating in the staff mentorship 
and buddy programme. 
 
2009 UC Academic Audit Working Group on the role of critic 
and conscience of society 
 
2007-2008 President, Association of University Staff (AUS) 
Canterbury Branch 
 
2006-2007 Canterbury representative AUS National Council 
 
2006 AUS National Bargaining Team 
 
2005-2006 Academic Representative (elected) on the Canterbury 
Branch AUS 
 
2005-2006 School of Biological Sciences Research Committee 
 
2002-continuing Chair, University Institutional Biosafety Committee 
 
2001-2003 Departmental Supervisor of Postgraduate Studies 
 
2002 University Teaching and Learning Committee 
 
2000-2001 Department HSNO-Biology Officer and University 
representative to the HSNO Consultative Group 
 
2002-2004 Department Safety Committee 
 
1996-2005 Chair (2000), University Joint Academic Student 
Grievance Committee 
 
1998-2001 Plant and Microbial Sciences Workload Committee 
 
1996-1998 Branch Committee of the Association of University Staff 
(AUS) 
 
1994-1998 Plant and Microbial Sciences Curriculum Committee 
 
1994-1998 Academic Supervisor of the Graduate Seminar Series 
 
PROFESSIONAL ORGANIZATIONS: 
1989-continuing American Society for Microbiology 
1994-continuing New Zealand Microbiology Society 
1995-2002  New Zealand Molecular Biology Society 
1998-2002 New Zealand Society for Biochemistry and Molecular Biology 
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2002-2004  New Zealand Association of Scientists 
 
SCIENCE and COMMUNITY: 
2008: Call for Government to invest more in agricultural research, Radio New Zealand, 
16.4.08. Arts to get the chop, The Dominion Post, 30.4.08. Executions and amputations 
as staff protest job cuts, Westport News, 29.4.08. Restructuring goes ahead, Westport 
News, 30.4.08. Plans for restructuring go ahead, Gisborne Herald, 30.4.08. Claims that 
GM foods are needed to avert a food crisis are rubbished, Radio New Zealand, 9.6.08; 
Claims that GM crops are needed to prevent food shortages are disputed by experts, 
Radio New Zealand, 9.6.08. 
 
2007: GM Corn, 30 minute interview on RNZ Nine to Noon programme 19.7.07; 
Discussion as to whether new type of genetically modified corn safe for human 
consumption, RNZ (Morning Report), 7.2.07; Food safety minister asked to reject new 
type of genetically modified corn, RNZ (6.00am news), 7.2.07; Minister asked to reject 
GM animal feed, New Zealand Herald, 7.2.07; Lobby tries to halt feed imports, 
Marlborough Express, 7.2.07; GM maize fears raised, Bay of Plenty Times, 7.2.07; Food 
lobbyists: Govt must act fast to stop GE corn, Northern Advocate, 8.2.07; Academic 
research under pressure, Gulf News, 15.2.07; Review of approval of genetically modified 
corn for animal feed, RNZ (Checkpoint), 21.2.07 
 
2006: The Press (Christchurch) “Gene claims a rationale for abuse” (15 August, p. A8); 
ABC Science Online “Food Regulator Criticised over new GM corn” (4 August); 
Interview National Radio’s Morning Report (6 June on High Lysine Corn); Interview 
National Radio’s Checkpoint (5 June on Corn Food Safety); The Press (Christchurch) 
Heinemann, J.A. 5 May 2006 Perspectives article “Alarm bells over GM food approval: 
part 2. Featured in New Zealand Herald 24.03.06 Company wants stockfeed GE corn 
approved for people; TVNZ and TV3 interview on Frank Sin’s “gay gene”, 6 and 10 pm 
news 13.03.06; Christchurch Press interview on Frank Sin’s “gay gene”. 
 
2005: Heinemann, J.A., Bungard, R. and Goven, J. Confidence in biotechnology 
requires greater commitment. 2005.3.3. Otago Daily Times p. 11. 
 
2004: Featured on Checkpoint (National RadioNZ, 25.05.04); Speaking engagements: 
March Presentation to the WEA; April Palmerston North branch of the Royal Society; 
Royal Society Parliament Series; July lecturer in National Science Teachers 
Conference; September Skeptics Society Annual Conference; Presenter in Natural 
History New Zealand pilot for Discovery “Dr. Know” series. 
 
2003: Heinemann, J.A. 9 May 2003. Economics of GE models fail to convince. 
National Business Review p. 21. Presentation to University of the Third Age. 
Heinemann, J.A. 25 August 2003. Food chain in NZ must be protected. New Zealand 
Herald p. A15. 
 
2000-2: Heinemann, J.A. 2002. GE or not to be. NZ Listener 185, 8. Interview (April 
2002), Morning Programme National Radio "Canterbury research wins international 
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accolades"; and CTV (same topic). Invited speaker for the New Zealand Association for 
Impact Assessment (May 2002). Instructor "Marvels and Menaces of Microscopic Life" 
University of Canterbury Continuing Education Course; "Radioactive" Wellington 
Student Radio interview on antibiotic resistance; Talk on horizontal gene transfer to 
Canterbury Botanical Society; Featured in news article by Pockley, P. 2000. New law 
threatens to undermine genetics in New Zealand. Nature 406, 8; Letter to the Editor of 
the Christchurch Press: “Genetic Engineering”; Interviewed by Paul Holmes (Auckland 
radio) for NewstalkZB (27 June); Radio New Zealand News interviews (30 June and 20 
July); Featured in 4 news articles by the Christchurch Press on genetic engineering 
regulations; Heinemann, J.A. June 2000. Open letter to Helen Clark. The Best 
Underground Press – Critical Review (6), 9, 2; University of Canterbury student 
newspaper CANTA articles: “Why do students but not academics have to be world-
class?” (10 May 2000) and "Teaching is as teachers do” (17 May 2000); Heinemann, 
J.A. 2000. Research hazards. New Zealand Education Review (Sept. 8, 2000, p. 9); 
Heinemann, J.A. 2000. National security risk. NZ Listener (Jul 7), 7-8; interview on 
horizontal gene transfer by CHTV (1 Nov.); interview National Programme Eureka! 
(Nov. 26-27, 2000); Heinemann, J.A. 2001. The fate of students within our hands. New 
Zealand Education Review (Jan. 12, 2001, p. 7). 
 
Presentations to Lions, Rotary (x2), WEA, University of the Third Age. 
 
1999: Talk on Genetically Modified Food to the Canterbury WEA; Talk on Genetically 
Modified Food to the Probus Club; Article to University of Canterbury public relations 
magazine, Canterbury Research, entitled: Are all Genes made of DNA? 
 
1998: Talk on Genetically Modified Food to the WEA Bishopdale Community Centre; 
Article to community magazine, City Habitat, entitled “What is a University?”; Article 
to community magazine, City Habitat, entitled “Why You Don't Want to be my 
Client”. 
 
1997: Interview National Programme, New Zealand Public Radio: “Superbugs”; Article 
to University of Canterbury public relations magazine, Canterbury Research, entitled: 
“The Life and Times of the Undead”; Debate Plains FM, Christchurch, New Zealand: 
“Risk and Ethics of Genetic Engineering”. 
 
1995: Interview National Programme, New Zealand Public Radio: “Antibiotic 
Resistance”; Advisor for a nationally ranked high school student science project 
competition. 
 
TOTAL PROFESSIONAL PUBLICATIONS:     81 
 
Peer-Reviewed Publications (*invited):     Total: 44 
Journals (32) 
 Heinemann, J.A. and Kurenbach, B. 2008. Special threats to the  
agroecosystem from the combination of genetically modified crops and  
glyphosate. Third World Network Biosafety Briefing, August 2008. 
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 Filutowicz, M., Burgess, R., Gameli, R.L., Heinemann, J.A., Kurenbach, B., 
Rakowski, S.A. and Shankar, R. 2008. Bacterial conjugation-based antimicrobial 
agents. Plasmid 60, 38-41. 
 
 Tsuei, A.C., Carey-Smith, G.V., Hudson, J.A., Billington, C. and Heinemann, J.A. 
2007. Prevalence and numbers of coliphages and Campylobacter jejuni 
bacteriophages in New Zealand foods. International Journal of Food Microbiology 
116, 121-125. 
 
Silby, M.W., Ferguson, G.C., Billington, C. and Heinemann, J.A. 2007. Localization 
of the plasmid-encoded proteins TraI and MobA in eukaryotic cells. Plasmid 57, 
118-130. 
 
Willms, A.R., Roughan, P.D. and Heinemann, J.A. 2006. Static recipient cells as 
reservoirs of antibiotic resistance during antibiotic therapy. Theoretical Population 
Biology 70, 436-451. 
 
Heinemann, J.A., Rosén, H., Savill, M., Burgos-Caraballo, S. and Toranzos, G.A. 
2006. Environment Arrays: A possible approach for predicting changes in water-
borne bacterial disease potential. Environmental Science and Technology 40, 7150-
7156. 
 
Carey-Smith, G., Billington, C., Cornelius, A.J., Hudson, A. and Heinemann, J.A. 
2006. Isolation and characterization of bacteriophages infecting Salmonella spp. 
FEMS Microbiology Letters 258, 182-186. 
 
Roy Chowdhury, P. and Heinemann, J.A. 2006. The General Secretory Pathway of 
Burkholderia gladioli pv. agaricicola, BG164R, is necessary for ‘Cavity Disease’ in 
white button mushrooms. Applied and Environmental Microbiology 72, 3558-
3565. 
 
 Cooper, T.F. and Heinemann, J.A. 2005. Selection for plasmid postsegregational 
killing depends on multiple infection: Evidence for the selection of more virulent 
parasites through parasite-level competition. Proceedings of the Royal Society 
London Biological Science Series B 272, 403-410. 
 
 Heinemann, J.A. and Traavik, T. 2004. Problems in monitoring horizontal gene 
transfer in field trials of transgenic plants. Nature Biotechnology 22, 1105-1109. 
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Are the meat, milk and eggs 
from livestock fed biotech feeds 
Yes!
FASS Facts
On Biotech Crops – Impact on Meat, Milk and Eggs
F E D E R A T I O N O F A N I M A L S C I E N C E S O C I E T I E S
safe toeat?
Background 
The term “biotechnology” has sparked controversy in recent
years. Much of the controversy is fueled by activist groups who
perceive genetic enhancement as somehow “unnatural.” There
are also concerns about introduction of genes that may produce
allergenic responses or have adverse effects on the environment.
However, biotechnology is a remarkable technology that has
produced many benefits to consumers. Unfortunately,
Americans don’t have the information they need to sort 
facts from fear about this technology and its benefits.
Today’s biotechnology is simply a more precise means of
doing what has been done for centuries through conventional
breeding – striving to develop crops and
foods that have desirable characteristics.
These characteristics might include 
protection against insect pests, which 
minimizes the need for pesticides; higher crop
yields; or improved nutritional properties.
Conventional plant breeding was done through trial and
error. Scientists could spend 10 to 15 years crossing plants and
growing them to bring out certain characteristics from the tens
of thousands of genes that each plant possesses. Oil seed rape
(the progenitor of canola) was one of the successes of this 
type of crossbreeding. In fact, rapeseed oil was an industrial 
lubricant unfit for human consumption until canola was 
genetically modified to become low erucic acid rapeseed oil,
which eliminated some of its anti-nutritional properties.Today,
it is one of the healthiest oils on the market. Most foods 
consumed today – like corn, wheat and tomatoes – are long-
term, conventional breeding success stories. And now, through
genetic modification, desirable traits can be selected and more
quickly incorporated rather than waiting a decade for results.
Genes from different species are often highly related.The
same genetic material may be found in multiple species. New
genetic material adds selected, special characteristics to the
new plant.These special characteristics or traits benefit 
everyone: both the consumer as well as the farmer.
Do Livestock Consume
Biotech Feeds?
Yes, livestock have been fed biotech
feeds since biotech crops were first
introduced in 1996. Recently,
livestock feeds have been improved
using modern methods of agricultural
biotechnology, such as recombinant
DNA technology.The application 
of recombinant DNA technology
frequently has been referred to 
as genetic modification. Crops
developed using modern methods 
of agricultural biotechnology are
referred to as biotech crops as opposed to crops developed
using conventional plant breeding.Two important types of
commercially available biotech crops include crops tolerant 
to herbicides and crops protected against insect pests.
Both conventional and biotechnology techniques have 
benefited agriculture immensely because they make feed more
plentiful and affordable.When inputs are less costly, so are the
outputs purchased by consumers: meat, milk and eggs. In fact,
we spend significantly less of our disposable income in the
United States on food than any other nation in the world 
thanks to the successes of our agricultural system, of which
agricultural biotechnology is a key part.
Why Do Farmers Raise Biotech Crops?
Farmers raise biotech crops because they are more reliable and
profitable than conventional crops.
First, the amount of insecticide applied to insect-protected
crops is reduced.Yields of corn, cotton and soybeans are
increased in many instances.The majority of these cost savings
are enjoyed by the grower. Overall, the cost of producing an
acre of the crop is reduced and some of these cost savings 
ultimately can be passed on to the consumer.
Since seeds for biotech corn and soybeans were first sold 
in the United States in 1996, farmers have continued to plant
increasing acreage. More than one-half of the soybeans and
more than one-third of the corn planted in 2000 were 
biotech crops.
Farmers and Consumers Enjoy 
the Benefits of Biotech Crops 
Consumers have reaped the benefits of biotech crops in the
form of higher quality products. In the future, consumers 
will see expanding benefits of biotech crops as the use and
sophistication of biotechnologies grow.
For example, a corn
called Bt corn has been
bred to be protected
against a common pest
called the European corn
borer.This results in less
damage to the corn plant
which, in turn, reduces
the infection by a fungus
that produces a mycotoxin
called fumonisin. Bt corn
varieties therefore contain
less fumonisin. Fumonisin
has been shown to be a
carcinogen in humans, so
risk of human exposure
to fumonisin from corn-
based products is being
reduced thanks to
biotechnology.
There will be many biotech crops with enhanced levels 
of nutrients or other beneficial substances in the plant. For
example, “golden rice” is being developed with increased 
levels of vitamin A and iron. Golden rice could be a significant
addition to the diet and health of many persons throughout the
world who are currently deficient in vitamin A. Other plants
will produce nutritionally enhanced oils, or will improve the
shelf life of the food.
Are Nutrients or Anti-Nutrients 
in Biotech Crops Different?
No, both the levels of nutrients and anti-nutrients in the 
current biotech crops are the same as in conventional crops. As
stated above, some crops are being developed which will have
increased levels of nutrients, including feeds, like the lysine and
methionine content in corn grain. Likewise, anti-nutrients, or
undesirable proteins, such as trypsin inhibitor in soybeans or
gossypol in cotton, are unchanged in biotech crops compared
to conventional crops.
Livestock feeds such as corn grain, whole-plant chopped
corn, corn stover and soybeans from the current biotech crops
have been compared with conventional feeds to measure any
changes in feed composition.The research clearly shows that
the levels of nutrients – such as protein, carbohydrates, fat,
energy, amino acids, fatty acids, minerals, vitamins and other
components of biotech and conventional feeds – are substantially
equivalent and are well within the normal range of values
reported in the scientific literature.
Are Biotech Feeds Safe for Livestock?
Yes, biotech feeds are safe for livestock. Livestock digest 
and absorb nutrients from biotech feeds in the same way they
do conventional feeds.The digestive process in all livestock
breaks down the nutritional components in feeds and uses 
these nutrients for the growth and development of the animal.
In addition, livestock growth, milk production, milk 
composition and health are not different, whether fed conventional
or biotech feeds. Over 30 different animal feed performance
studies have been conducted. All of these studies have shown
that corn grain or soybean meal from biotech plants performs
similarly to the grain or meal from conventional plant varieties.
Are Nutrients in Meat,
Milk and Eggs Different?
Nutrients in meat, milk and eggs 
from livestock fed biotech feeds are 
the same as those from livestock fed
conventional feeds. Because most 
components of feeds are broken into smaller components 
during digestion by the animal, plant proteins have not been
detected in milk, meat or eggs.
The introduced DNA and newly expressed protein(s) from
biotech crops have not been found in the meat, milk or eggs
from animals fed biotech crops.
Are Meat, Milk and Eggs Safe to Eat?
Yes, meat, milk and eggs from livestock and poultry consuming
biotech feeds are safe for human consumption. By 2020, global
protein consumption from meat, milk and eggs is predicted to
increase dramatically, a “Livestock Revolution.” Therefore, with
biotech crops and animal food products, we will benefit the
nutrition and well-being of the world’s population, especially
children in developing countries.
U.S. Government Agencies Heavily
Regulate Biotech Crops by Requiring
Extensive Field and Safety Tests
FOOD AND DRUG 
ADMINISTRATION (FDA)
The FDA ensures that any human
food or animal feed derived from
new plant varieties are safe to eat.
After completion of the voluntary
FDA consultation process, more
than 40 crops have been developed
for market.The FDA has recently
proposed to change the process
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from voluntary to mandatory. Foods derived from biotechnology
must be labeled only if they differ significantly from their 
conventional counterparts. For example, if the nutritional 
value or the potential to cause an allergic reaction is altered.
UNITED STATES DEPARTMENT 
OF AGRICULTURE (USDA)
The USDA is the U.S. government’s lead agency regulating the
safe field-testing of new biotech plant varieties. Impact on the
environment, on endangered or threatened species and on
“non-target” species are all considered.
ENVIRONMENTAL PROTECTION AGENCY (EPA)
The EPA has authority over all new pesticides, including
biotech plants, which produce their own protection against
pests. In deciding whether to register a new biotech product,
the EPA considers human safety, impact on the environment,
effectiveness on the targeted pest and any effects on other
endangered and threatened species.
Recently StarLink corn, which was approved only for 
animal consumption, was found in human foods.The EPA now
has a policy of not approving biotech crops intended for animal
feeding without simultaneously approving the crops for human
use.This action is taking precautions against a recurrence of a
StarLink situation.
Should We Label the Meat, Milk and Eggs?
FASS recognizes the significant logistical problems that labeling
incurs for meat, poultry, egg and milk processors. FASS does
not support labeling of food derived from animals fed biotech
crop materials because the scientific evidence consistently 
indicates that meat, milk and eggs derived from animals fed
biotech feeds are equivalent to
products from animals fed 
conventional feeds. FASS supports
food labeling that is meaningful to
the consumer and serves a specific
purpose. FASS supports food 
labeling if a food product is 
substantially changed in nutritional
composition or safety.
Conclusions
The Federation of Animal Science Societies has reviewed the
scientific information concerning the consumption of biotech
feeds by livestock.We conclude that:
• Acceptance of biotech feeds for livestock must be based
on sound science;
• The use of biotechnology techniques will be essential 
to improving agricultural plants and animal products;
• Agricultural biotechnology is capable of improving 
supplies of livestock feeds and healthful animal and 
plant food products;
• The safety of meat, milk and eggs is adequately assured 
by the science-based risk assessment procedures used by
government agencies and developers;
• The DNA introduced in biotech plants and the proteins
encoded by this DNA have not been detected in the meat,
milk or eggs from animals fed these products; and
• Meat, milk and eggs from animals fed biotech
feeds are safe for human consumption.
For more information, contact the Federation
of Animal Science Societies.
The Federation of Animal Science Societies
(FASS) is a professional organization made up 
of approximately 10,000 scientists in academia,
government and industry which exists to serve
society through the improvement of all aspects 
of food animal production. FASS represents the
combined memberships of the American Dairy
Science Association, the American Society 
of Animal Science and the 
Poultry Science Association.
